Flebogamma 5% DIF

Flebogamma 5% DIF Indications/Uses

human normal immunoglobulin

Manufacturer:

Grifols

Distributor:

DKSH
Full Prescribing Info
Indications/Uses
Flebogamma 5% DIF is indicated for: Replacement therapy in: Primary immunodeficiency syndromes such as: congenital agammaglobulinaemia and hypogammaglobulinaemia; common variable immunodeficiency; severe combined immunodeficiency; Wiskott Aldrich syndrome.
Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.
Children with congenital AIDS and recurrent infections.
Immunomodulation: Idiopathic thrombocytopenic purpura (ITP), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.
Guillain Barré syndrome.
Kawasaki disease.
Allogeneic bone marrow transplantation.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in